サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1753996

末梢動脈疾患市場レポート：タイプ、エンドユーザー、地域別、2025～2033年

Peripheral Artery Disease Market Report by Type, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 149 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.06円
末梢動脈疾患市場レポート：タイプ、エンドユーザー、地域別、2025～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の末梢動脈疾患市場規模は2024年に49億米ドルに達しました。今後、IMARC Groupは、2033年に同市場が77億米ドルに達し、2025～2033年の成長率（CAGR）は4.98%になると予測しています。高齢者数の増加、診断・治療における様々な技術革新、在宅ケアの導入拡大、ヘルスケアインフラの改善、個人の生活水準の変化などが市場成長を後押ししています。

末梢動脈疾患（PAD）は、動脈が収縮して手足への血流が制限される心血管系の疾患です。その結果、脱毛、脚のしびれ、足の指のただれ、臀部や大腿部の痛みを伴うけいれん、脚の冷えや脈の弱さ、男性の勃起不全などが生じます。心臓から腕や脚に酸素や栄養豊富な血液を運ぶ脚の動脈に、アテローム性動脈硬化症としても知られるプラークが発生することで発症します。足関節上腕血圧比、超音波検査、血管造影、血液検査、ドップラーと超音波（デュプレックス）画像、コンピュータ断層撮影（CT）、磁気共鳴血管造影（MRA）などを用いて診断します。末梢動脈疾患市場概要では、糖尿病や高血圧などの危険因子に対する意識の高まりや有病率の増加により、PADの管理や治療においてより効果的なソリューションが求められているため、先進的診断や治療オプションに対する需要が増加していることを示しています。

末梢動脈疾患市場動向

低侵襲手術における技術の進歩

洗練されたカテーテルベースの機器や技術の開発は血管インターベンションに革命をもたらし、従来型開腹手術に代わる低侵襲手術を提供しています。これらの進歩は、患者の不快感を軽減し、入院期間を短縮し、回復時間を短縮することにより、治療成績を著しく向上させています。高度血管形成術用バルーン、薬剤コーティングバルーン、アテレクトミー装置、特殊ステントなどの新しい装置は、PADに利用可能な治療選択肢の幅を広げています。これらの技術革新は、より高い柔軟性、送達性、有効性を提供し、臨床医が複雑な病変をより効果的に治療することを可能にしています。さらに、これらの侵襲の少ない手技は、長期開存率を向上させながら正常な血管解剖学的構造を維持し、全体的な転帰の改善につながります。末梢動脈疾患の市場動向は、より先進的で患者に優しい治療法へのシフトを示しており、PAD患者にとってより良い臨床結果と生活の質の向上を可能にする革新的な機器への需要が高まっています。

個人の生活水準の変化

糖尿病、肥満、高血圧、喫煙などの生活習慣に関連した要因によって、PADを患う人が増えています。世界的にこれらの疾患の割合が増加するにつれ、特に高齢化が進んでいる地域では、より多くの人がPADの危険にさらされています。糖尿病は動脈硬化の一因となり、動脈を狭くして血流を制限し、PADにつながります。その結果、血管形成術、ステント留置術、バイパス手術などの診断ツールや治療に対する需要が高まっています。さらに、心血管疾患（CVDs）の世界の負担は、PADの早期発見と管理に重点を置くようヘルスケアシステムを後押ししています。

人口の高齢化

世界の高齢化は市場成長を促す重要な要因です。高齢者は加齢に伴う血管の変化や動脈硬化のためにPADを発症するリスクが高いです。高齢になると動脈は自然に弾力性を失い、その結果、PADの特徴である動脈の狭窄や閉塞を引き起こす可能性があります。この人口動態の変化は、診断、予防治療、血管形成術やステント留置術のような低侵襲性（MI）インターベンションを含むヘルスケアサービスへの需要を促進します。これに伴い、ヘルスケアプロバイダは、複雑な健康プロファイルを持つことが多い高齢患者のニーズへの対応にますます注力するようになっており、これが末梢動脈疾患市場の成長に寄与しています。

本レポートで扱う主要質問

  • 末梢動脈疾患の世界市場規模は？
  • 2025～2033年における末梢動脈疾患の世界市場予測成長率は？
  • 末梢動脈疾患の世界市場を牽引する主要因は？
  • 末梢動脈疾患の世界市場に対するCOVID-19の影響は？
  • 末梢動脈疾患の世界市場におけるタイプ別区分は？
  • 末梢動脈疾患の世界市場における主要地域は？
  • 末梢動脈疾患の世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の末梢動脈疾患市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 末梢血管形成術用バルーン
  • 末梢ステント
  • 末梢カテーテル
  • 下大静脈（IVC）フィルター
  • プラーク修正デバイス
  • 血行動態血流調節デバイス
  • 周辺機器付属品

第7章 市場内訳：エンドユーザー別

  • 病院
  • 専門クリニック
  • その他

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • AngioDynamics
    • B. Braun Melsungen AG
    • Becton Dickinson and Company
    • BIoTronik SE & Co. KG
    • Boston Scientific Corporation
    • Cardinal Health Inc.
    • Cook Medical LLC
    • Koninklijke Philips N.V.
    • Medtronic plc
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Peripheral Artery Disease Market: Major Drivers and Challenges
  • Figure 2: Global: Peripheral Artery Disease Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Peripheral Artery Disease Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Peripheral Artery Disease Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Peripheral Artery Disease Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Peripheral Artery Disease Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Peripheral Artery Disease (Peripheral Angioplasty Balloons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Peripheral Artery Disease (Peripheral Angioplasty Balloons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Peripheral Artery Disease (Peripheral Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Peripheral Artery Disease (Peripheral Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Peripheral Artery Disease (Peripheral Catheters) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Peripheral Artery Disease (Peripheral Catheters) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Peripheral Artery Disease (Inferior Vena Cava (IVC) Filters) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Peripheral Artery Disease (Inferior Vena Cava (IVC) Filters) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Peripheral Artery Disease (Plaque Modification Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Peripheral Artery Disease (Plaque Modification Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Peripheral Artery Disease (Hemodynamic Flow Alteration Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Peripheral Artery Disease (Hemodynamic Flow Alteration Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Peripheral Artery Disease (Peripheral Accessories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Peripheral Artery Disease (Peripheral Accessories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Peripheral Artery Disease (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Peripheral Artery Disease (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Peripheral Artery Disease (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Peripheral Artery Disease (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Peripheral Artery Disease (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Peripheral Artery Disease (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: North America: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: North America: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: United States: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: United States: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Canada: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Canada: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Asia-Pacific: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Asia-Pacific: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: China: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: China: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Japan: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Japan: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: India: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: India: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: South Korea: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: South Korea: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Australia: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Australia: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Indonesia: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Indonesia: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Others: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Others: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Europe: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Europe: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Germany: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Germany: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: France: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: France: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: United Kingdom: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: United Kingdom: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Italy: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Italy: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Spain: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Spain: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Russia: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Russia: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Latin America: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Latin America: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Brazil: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Brazil: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Mexico: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Mexico: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Middle East and Africa: Peripheral Artery Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Middle East and Africa: Peripheral Artery Disease Market: Breakup by Country (in %), 2024
  • Figure 75: Middle East and Africa: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Global: Peripheral Artery Disease Industry: SWOT Analysis
  • Figure 77: Global: Peripheral Artery Disease Industry: Value Chain Analysis
  • Figure 78: Global: Peripheral Artery Disease Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Peripheral Artery Disease Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Peripheral Artery Disease Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Peripheral Artery Disease Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 4: Global: Peripheral Artery Disease Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Peripheral Artery Disease Market: Competitive Structure
  • Table 6: Global: Peripheral Artery Disease Market: Key Players
目次
Product Code: SR112025A5822

The global peripheral artery disease market size reached USD 4.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.98% during 2025-2033. The rising number of geriatric populations, various technological innovations in the diagnosis and treatment, increasing adoption of home care settings, improvement in healthcare infrastructure, and changing living standards of individuals are propelling the market growth.

Peripheral artery disease (PAD) is a cardiovascular disorder wherein constricted arteries restrict blood flow to the limbs. It results in hair loss, leg numbness, feet or toe sores, painful cramps in hips and thighs, coldness and weak pulse in legs, and erectile dysfunction among men. It is caused when a plaque, also known as atherosclerosis, develops in leg arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs. It is diagnosed using the ankle-brachial index, ultrasound scan, angiography, blood tests, doppler and ultrasound (duplex) imaging, computed tomographic angiography (CT), and magnetic resonance angiography (MRA). The peripheral artery disease market overview indicates an increasing demand for advanced diagnostic and treatment options, as rising awareness and the growing prevalence of risk factors such as diabetes and hypertension are pushing for more effective solutions in managing and treating PAD.

Peripheral Artery Disease Market Trends:

Technological Advancements in Minimally Invasive Surgeries

The development of sophisticated catheter-based devices and techniques is revolutionizing vascular interventions, offering less invasive alternatives to traditional open surgeries. These advancements are significantly improving treatment outcomes by reducing patient discomfort, shortening hospital stays, and enabling faster recovery times. New devices, such as advanced angioplasty balloons, drug-coated balloons, atherectomy devices, and specialized stents, are expanding the range of treatment options available for PAD. These innovations offer greater flexibility, deliverability, and efficacy, allowing clinicians to treat complex lesions more effectively. Furthermore, these less invasive procedures preserve normal vascular anatomy while improving long-term patency rates, leading to better overall outcomes. The peripheral artery disease market trends show a shift towards more advanced, patient-friendly treatment options, with increasing demand for innovative devices that enable better clinical results and improved quality of life for PAD patients.

Changing Living Standards of Individuals

People are increasingly suffering from peripheral artery disease (PAD) due to lifestyle-related factors, such as diabetes, obesity, hypertension, and smoking. As global rates of these conditions increase, particularly in regions with aging populations, more individuals are at risk of PAD. Diabetes contributes to atherosclerosis, which narrows arteries and restricts blood flow, leading to PAD. As a result, the demand for diagnostic tools and treatments, such as angioplasty, stenting, and bypass surgery, is rising. Additionally, the global burden of cardiovascular diseases (CVDs) is pushing healthcare systems to focus on early detection and management of PAD.

Aging Population

The global aging population across the globe is a crucial factor impelling the market growth. Older adults face a higher risk of developing PAD owing to age-related vascular changes and atherosclerosis. As people age, their arteries naturally lose elasticity, which can result in narrowed or blocked arteries, a hallmark of PAD. This demographic shift drives demand for healthcare services including diagnostics, preventive treatments, and minimally invasive (MI) interventions like angioplasty and stent placement. In line with this, healthcare providers are increasingly focusing on addressing the needs of elderly patients, who often have complex health profiles, which is thereby contributing to the peripheral artery disease market growth.

Key Market Segmentation:

Breakup by Type:

  • Peripheral Angioplasty Balloons
  • Peripheral Stents
  • Peripheral Catheters
  • Inferior Vena Cava (IVC) Filters
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Peripheral Accessories

Breakup by End User:

  • Hospitals
  • Specialty Clinics
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The peripheral artery disease market research report has also provided a comprehensive analysis of the competitive landscape in the global market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Abbott Laboratories
  • AngioDynamics
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Terumo Corporation

Key Questions Answered in This Report

  • 1.How big is the global peripheral artery disease market?
  • 2.What is the expected growth rate of the global peripheral artery disease market during 2025-2033?
  • 3.What are the key factors driving the global peripheral artery disease market?
  • 4.What has been the impact of COVID-19 on the global peripheral artery disease market?
  • 5.What is the breakup of the global peripheral artery disease market based on the type?
  • 6.What are the key regions in the global peripheral artery disease market?
  • 7.Who are the key players/companies in the global peripheral artery disease market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Peripheral Artery Disease Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Peripheral Angioplasty Balloons
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Peripheral Stents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Peripheral Catheters
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Inferior Vena Cava (IVC) Filters
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Plaque Modification Devices
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hemodynamic Flow Alteration Devices
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Peripheral Accessories
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Specialty Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 AngioDynamics
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 B. Braun Melsungen AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 Becton Dickinson and Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Biotronik SE & Co. KG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Boston Scientific Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Cardinal Health Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Cook Medical LLC
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 SWOT Analysis
    • 13.3.9 Koninklijke Philips N.V.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Medtronic plc
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Terumo Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis